1. Home
  2. ALMS vs PPT Comparison

ALMS vs PPT Comparison

Compare ALMS & PPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • PPT
  • Stock Information
  • Founded
  • ALMS 2021
  • PPT 1988
  • Country
  • ALMS United States
  • PPT United States
  • Employees
  • ALMS N/A
  • PPT N/A
  • Industry
  • ALMS
  • PPT Finance Companies
  • Sector
  • ALMS
  • PPT Finance
  • Exchange
  • ALMS NYSE
  • PPT Nasdaq
  • Market Cap
  • ALMS 402.6M
  • PPT 346.9M
  • IPO Year
  • ALMS 2024
  • PPT N/A
  • Fundamental
  • Price
  • ALMS $4.10
  • PPT $3.65
  • Analyst Decision
  • ALMS Strong Buy
  • PPT
  • Analyst Count
  • ALMS 6
  • PPT 0
  • Target Price
  • ALMS $19.80
  • PPT N/A
  • AVG Volume (30 Days)
  • ALMS 692.8K
  • PPT 156.1K
  • Earning Date
  • ALMS 08-12-2025
  • PPT 01-01-0001
  • Dividend Yield
  • ALMS N/A
  • PPT 8.84%
  • EPS Growth
  • ALMS N/A
  • PPT N/A
  • EPS
  • ALMS N/A
  • PPT N/A
  • Revenue
  • ALMS $17,389,000.00
  • PPT N/A
  • Revenue This Year
  • ALMS N/A
  • PPT N/A
  • Revenue Next Year
  • ALMS N/A
  • PPT N/A
  • P/E Ratio
  • ALMS N/A
  • PPT N/A
  • Revenue Growth
  • ALMS N/A
  • PPT N/A
  • 52 Week Low
  • ALMS $2.76
  • PPT $3.25
  • 52 Week High
  • ALMS $13.20
  • PPT $3.72
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • PPT 50.42
  • Support Level
  • ALMS N/A
  • PPT $3.59
  • Resistance Level
  • ALMS N/A
  • PPT $3.66
  • Average True Range (ATR)
  • ALMS 0.00
  • PPT 0.03
  • MACD
  • ALMS 0.00
  • PPT 0.00
  • Stochastic Oscillator
  • ALMS 0.00
  • PPT 61.11

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About PPT Putnam Premier Income Trust

Putnam Premier Income Trust is a Massachusetts business trust operating as a non-diversified closed-end management investment company. The fund is currently operating as a diversified fund. Its investment objective is to seek high current income consistent with the preservation of capital by allocating its investments to the U.S. government sector.

Share on Social Networks: